Table 3.
Men | P value | Women | P value | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | |||
Crude | 9.05 ± 1.46 | 9.23 ± 1.47 | 9.18 ± 1.43 | 9.36 ± 1.45 | ≤.001 | 8.37 ± 1.34 | 8.46 ± 1.33 | 8.65 ± 1.42 | 8.69 ± 1.39 | ≤.001 |
Model 1 | 9.13 ± 1.30 | 9.19 ± 1.29 | 9.14 ± 1.27 | 9.35 ± 1.30 | .002 | 8.47 ± 1.16 | 8.50 ± 1.19 | 8.58 ± 1.18 | 8.59 ± 1.19 | .043 |
Model 2 | 9.12 ± 1.30 | 9.19 ± 1.29 | 9.14 ± 1.30 | 9.36 ± 1.30 | .001 | 8.49 ± 1.19 | 8.51 ± 1.15 | 8.57 ± 1.18 | 8.57 ± 1.19 | .232 |
Model 3 | 9.14 ± 1.33 | 9.20 ± 1.29 | 9.13 ± 1.27 | 9.34 ± 1.35 | .007 | 8.48 ± 1.19 | 8.51 ± 1.15 | 8.57 ± 1.18 | 8.57 ± 1.22 | .247 |
Model 1 was adjusted by age and SBP; Model 2 was adjusted by Model 1 + BMI and uric acid; Model 3 was adjusted by Model 2 + fasting glucose, eGFR, and K excretion.